Merit Medical Q3 revenue $315.2M (+9.8% YoY); GAAP EPS $0.44, adjusted $0.75; guides up

MERIT MEDICAL SYSTEMS INC

2023-Q3 EPS reported $1.14 revenue$932,851,000

Q3 revenue $315.2M, up 9.8% YoY; constant currency revenue up 9.7%, organic constant currency up 7.1%.
GAAP operating margin 11.1% vs 6.5% in Q3 2022; non-GAAP operating margin 18.3% vs 16.1%.
GAAP EPS $0.44 (up from $0.27); non-GAAP EPS $0.75 (up from $0.64).
Company raises fiscal year 2023 financial guidance.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

MERIT MEDICAL SYSTEMS INC reported for the quarter ended September 30, 2023 results: revenue $315.2 million, EPS $0.44. Guidance raised.

Period: for the quarter ended September 30, 2023
Revenue: $315.2 million
EPS: $0.44
Guidance: raised
Result: reported results

Exact text from the filing

mike.piccinino@westwicke.com FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS RESULTS FOR THIRD QUARTER ENDED SEPTEMBER 30, 2023 ● Q3 2023 reported revenue of $315.2 million, up 9.8% year-over-year ● Q3 2023 constant currency revenue* up 9.7% year over year ● Q3 2023 constant currency revenue, organic* up 7.1% year-over-year ● Q3 2023 GAAP operating

View on SEC.gov

Browse all earnings releases →

MERIT MEDICAL SYSTEMS INC filing history →

Source: SEC EDGAR

accession 0000856982-23-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.